JENNIFER PRICE: Open Payments
NPI 1366794364 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 77 payments from 14 companies in 2025. Trend: 2023 $672 · 2024 $1,325 · 2025 $1,336
Food & beverage: $1,291Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $267 |
| Amgen Inc. | 21 | $255 |
| ABBVIE INC. | 12 | $205 |
| UCB, Inc. | 8 | $149 |
| Janssen Biotech, Inc. | 4 | $112 |
| Abbott Laboratories | 2 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $23 |
Products named: COSENTYX, RINVOQ, OTEZLA, Bimzelx, TREMFYA, FREESTYLE LIBRE 3, ACTHAR, Kerendia.
Industry payments across LA — which companies pay providers there.
